All Resources

Our resource hub to discover reports, policy papers and other forms of informative content

Filter by

Cost Drivers Report 2023

Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic.
Read the full report.

Learn more | View

Cost of A Private Drug Plan Claim

IMC contracted Reformulary Group to analyze the cost of a private plan prescription drug claim in Canada, and separately in Quebec. This report summarizes that analysis.

Learn more | View


Discover. Learn.

Informative content to keep you up to date on the most pressing issues facing our industry.